Mycoplasmas and Human prostate cancer: An exciting but cautionary note
Mycoplasmas and Human prostate cancer: An exciting but cautionary note |
|
https://doi.org/10.18632/oncotarget.282
Shyh-Ching Lo,
and Shien Tsai
|
| 352-355 |
Proteotoxic stress targeted therapy (PSTT)
Proteotoxic stress targeted therapy (PSTT) |
|
https://doi.org/10.18632/oncotarget.284
Michael Y. Sherman
|
| 356-357 |
Xenotropic murine leukemia virus-related virus (XMRV) in prostate cancer cells likely represents a laboratory artifact
Xenotropic murine leukemia virus-related virus (XMRV) in prostate cancer cells likely represents a laboratory artifact |
|
https://doi.org/10.18632/oncotarget.287
Jiawen Yang,
Partho Battacharya,
Ruchi Singhal,
and Eugene S. Kandel
|
| 358-362 |
Netrin-1 overexpression is predictive of ovarian malignancies
Netrin-1 overexpression is predictive of ovarian malignancies |
|
https://doi.org/10.18632/oncotarget.258
Anastasios D. Papanastasiou,
Georgios Pampalakis,
Dionyssios Katsaros,
and Georgia Sotiropoulou
|
| 363-367 |
Class III β-Tubulin Counteracts the Ability of Paclitaxel to Inhibit Cell Migration
Class III β-Tubulin Counteracts the Ability of Paclitaxel to Inhibit Cell Migration |
|
https://doi.org/10.18632/oncotarget.250
Anutosh Ganguly,
Hailing Yang,
and Fernando Cabral
|
| 368-377 |
Network Modeling of MDM2 Inhibitor-Oxaliplatin Combination Reveals Biological Synergy in wt-p53 solid tumors
Network Modeling of MDM2 Inhibitor-Oxaliplatin Combination Reveals Biological Synergy in wt-p53 solid tumors |
|
https://doi.org/10.18632/oncotarget.269
Asfar S. Azmi,
Sanjeev Banerjee,
Shadan Ali,
Zhiwei Wang,
Bin Bao,
Frances WJ Beck,
Anthony F. Shields,
Philip Philip,
Fazlul H. Sarkar,
and Ramzi M. Mohammad
|
| 378-392 |
No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis
No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis |
|
https://doi.org/10.18632/oncotarget.278
Katharina Bluemlein,
Nana-Maria Grüning,
René G. Feichtinger,
Hans Lehrach,
Barbara Kofler,
and Markus Ralser
|
| 393-400 |
YB-1 drives preneoplastic progression: Insight into opportunities for cancer prevention
YB-1 drives preneoplastic progression: Insight into opportunities for cancer prevention |
|
https://doi.org/10.18632/oncotarget.276
Alastair H. Davies,
and Sandra E. Dunn
|
| 401-406 |
Casein kinase 2 phosphorylation of Hsp90 threonine 22 modulates chaperone function and drug sensitivity
Casein kinase 2 phosphorylation of Hsp90 threonine 22 modulates chaperone function and drug sensitivity |
|
https://doi.org/10.18632/oncotarget.272
Mehdi Mollapour,
Shinji Tsutsumi,
Yeong Sang Kim,
Jane Trepel,
and Len Neckers
|
| 407-417 |
Novel insights into the synergistic interaction of Bortezomib and TRAIL: tBid provides the link
Novel insights into the synergistic interaction of Bortezomib and TRAIL: tBid provides the link |
|
https://doi.org/10.18632/oncotarget.277
Simone Fulda
|
| 418-421 |
c-JUN prevents methylation of p16INK4a (and Cdk6): the villain turned bodyguard
c-JUN prevents methylation of p16INK4a (and Cdk6): the villain turned bodyguard |
|
https://doi.org/10.18632/oncotarget.279
Karoline Kollmann,
Gerwin Heller,
and Veronika Sexl
|
| 422-427 |
